Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Biofrontera logo

Biofrontera

Recent Finacing

Series C II

Recent Raise

$2.5M

Biofrontera is a dermatology-focused healthcare company that develops and commercializes the photodynamic therapy products Ameluz gel and RhodoLED lamp for skin conditions such as actinic keratosis and acne.

Nordrhein-Westfalen, Germany
51-100
Publicly Traded
biofrontera.com
PitchBook

Highlights

Focus Areas

Biopharma
Health Care
Pharmaceutical

Financials

$12M

Valuation as of 10/24/2025

$2.5M

Total Raised

1

Funding round


Team

Upgrade to view the team

See the team members at Biofrontera.